Navigation Links
UK and US guidelines on kids' physical activity levels need rethinking
Date:6/29/2008

UK and US guidelines on how much physical activity children need to boost their health and stave off obesity need to be revised, conclude researchers in a study published ahead of print in the Archives of Disease in Childhood.

What's more, less than half of boys and only one in eight girls manage the recommended weekly amounts.

The researchers base their findings on the long term monitoring of 113 boys and 99 girls from 54 different schools, all of whom were 5 years old when the study started.

The children were part of the EarlyBird study, which is tracking the long term health of 307 children born between 1995 and 1996.

The children's weekly physical activity levels were measured using a tiny device worn around the waist and designed for the purpose.

And changes in weight and predictive health indicators, such as insulin resistance, blood fat and cholesterol levels, and blood pressure were measured annually between the ages of 5 and 8.

Taken together, these health indicators reflect the risk of developing cardiovascular disease and diabetes.

Both the UK and US guidelines recommend that children are moderately physically active for at least an hour every day, in a bid to stave off obesity and its attendant health risks. And they measure body mass index (weight) to monitor impact

The results showed that there was a wide range of physical activity among children, some spending as little as 10 minutes a day at the recommended intensity while others were spending over 90 minutes a day.

Around 42% of boys but only 11% of girls met the 60 minute guideline.

There was no difference in weight (BMI) change between those who did and did not meet the guidelines.

But both boys and girls who met the guidelines showed progressive improvement in their predictive health indicators, while those who did not showed a progressive deterioration.

The authors suggest that
'/>"/>

Contact: Rachael Davies
rdavies@bma.org.uk
44-020-738-36529
BMJ-British Medical Journal
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Rheumatoid Arthritis Treatment Guidelines Updated
2. New blood clot guidelines for pregnant women
3. Alexian Brothers Hospital Network Receives American Stroke Associations Get With The Guidelines Gold Performance Achievement Award
4. International Committee Recommends Stringent Guidelines for Translating Stem Cell Therapies From the Lab Bench to the Bedside
5. Tufts researcher leads revision of osteoporosis guidelines
6. Dermatologists Release Psoriasis Care Guidelines
7. Treatment guidelines lead to four-fold increase in survival rate for cardiac arrest
8. American Academy of Dermatology Issues New Guidelines for the Management of Psoriasis and Psoriatic Arthritis
9. eHealth Initiative and the Center for Improving Medication Management to Present Report Detailing Both Impact of E-Prescriptions on U.S. Health Care System and Guidelines for Achieving Optimal Results
10. New Guidelines Issued for Implanted Heart Devices
11. The American College of Cardiology, American Heart Association and the Heart Rhythm Society Release Updated Cardiac Device-Based Therapy Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...ewswire/ -- Ingenious Med (IM) welcomes new CEO, S...in inpatient practice,management solutions, with ...,software, revenue management, medical services, ...e-year CEO, Dr. Steven Liu, is confident Williford...nt in all sectors, as he steps into,the role. Liu...
(Date:12/2/2008)... who took it in first 3 months more likely to have...ealthDay News) -- Infants whose mothers take folic...increased risk for respiratory illness, according ...o reduce the risk of birth defects, and many count... researchers examined data on more than 32,000 chi...
(Date:12/2/2008)...earchers at The University of Nottingham has ident...er. , The research, published in the journal Pr...A and funded by a 72,000 grant from the British Lu...r gene, LIMD1, is responsible for protecting the b...r possible new treatments and early screening tech...
(Date:12/2/2008)...cs, Inc., a privately held biopharmaceutical compa...s evaluating its lead investigational product cand...1, a novel, proprietary fixed-dose combination pro...ated a statistically significant reduction in the ...(NSAID)-induced upper gastrointestinal (gastric an...
Breaking Medicine News(10 mins):Health News:Ingenious Med Hires New CEO to Maintain and Further Expand Company Development 2Health News:Folate in Early Pregnancy May Boost Wheezing in Baby 2Health News:Gene which protects against lung cancer identified 2Health News:Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints 2
...ystatin C test appears to be a good alternative fo...ular disease, that the creatinine test might miss/...ancisco VA Medical Center, has shown the inefficac... is incapable of picking up chronic health risks a...
...rchers from the US have shown that yellow plant pi...oping// age-related macular degeneration (AMD). Th...ity of Wisconsin, which has been published in the ...carrots might not actually help a person in the da...
...perimental RNA-based drug acts by using genetic ma..., and another type, called silencing RNA// , to st...s alive, thereby destroying prostate cancer cells ... The drug, developed at Duke University Medical C...
...aining popularity of unpasteurized milk has raised... While people consume unpasteurized milk for a var...g that unpasteurized milk are healthier and tastie... who consume it do fall sick. There been have ins...
Other Medicine News:Health News:Cystatin C Test- A Reliable Test to Detect Chronic Health Risks 2Health News:Cystatin C Test- A Reliable Test to Detect Chronic Health Risks 3Health News:Yellow Fruits And Vegetables Help In Fight Against Loss Of Eyesight 2
(Date:12/1/2008)...irl with Hypophosphatasia Treated With ENB-0040 at...nnipeg , , MONTREAL, Dec. 1 ...ny focused on developing novel therapeutics for se...st infant patient in its clinical program for hypo...zyme Replacement Therapy (ERT) with ENB-0040 for t...
(Date:12/1/2008)...TH MEETING, Pa., Dec. 1 ...nced that dosing of subjects has begun in study MS...se Phase 1b study of trodusquemine (MSI-1436) in o...a novel therapeutic for the treatment of type 2 di...herally to regulate insulin and leptin pathways th...
(Date:12/1/2008)...A, Dec. 1 GeoVax Labs, I...biotechnology company developing,human vaccines f...y Virus) and,other infectious agents, announced t...e Trials will take place in twelve sites across No... in collaboration with The National Institutes of,...
(Date:11/30/2008)...O, Dec. 1 Abnormalities...ted in children with autism spectrum disorder by u...study presented today at the annual meeting of the... , "Using MEG, we can record the tiny magneti...," said Timothy Roberts, Ph.D., vice chair of rese...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Disability payments may spur drug abuse 14 1Disability payments may spur drug abuse 14 2MRI finds breast cancer before it becomes dangerous 9 1MRI finds breast cancer before it becomes dangerous 9 2MRI finds breast cancer before it becomes dangerous 9 3Survival differences by race most apparent in advanced stages of breast cancer 4 1Survival differences by race most apparent in advanced stages of breast cancer 4 2New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long Term Results 96 1New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long Term Results 96 2New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long Term Results 96 3
GE's Signa Contour/i system uses the latest innovations from around the world to bring new standards in quality and value to MRI.
Intera 3.0T is the most compact high-field clinical whole-body MR system in the world, bringing 3.0T capabilities "out of the tunnel" and into the light of an open, patient-friendly design.
The Akbarnia PDR Instruments are specially designed to help surgeons negotiate in and around vertebral structures in posteriolateral decompression and reconstruction procedures. The instruments featu
...y Platelet Concentrate System is a point-of-care s...et Concentrate (also referred to as Platelet Rich ...a small sample of blood. The Symphony PCS concentr...found in the platelets. The platelet concentrate c...
Medicine Products: